A study on patients with salivary gland tumours highlighted a similar phenomenon, whereby MCP‐1 expression was lower in patients with advanced stage disease, citing that this low expression likely confirmed inadequate recruitment of the mononuclear inflammatory cells necessary to mount an effective anti‐tumour cytotoxic response.28 The gene discussed is CCL2; the disease is neoplasm.